Noosa News
Brisbane company wins European approval for rapid COVID-19 tests
A Brisbane-based firm has won approval from European regulators to sell its 15-minute COVID-19 rapid test.
The company, AnteoTech, has been given the Conformitè Europëenne Mark registration for its antigen rapid test, EuGeni.
AnteoTech chief executive Derek Thomson.
The reusable test, which now meets crucial health and safety conditions in Europe and the United Kingdom, is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the…
-
Noosa News17 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General15 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General23 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
General19 hours agoMan dies at shopping centre car park at Charlestown following reports of assault